Fractyl Health Announces Groundbreaking Data from REMAIN-1 Midpoint Cohort Showing Revita Maintained Weight Loss After GLP-1 Discontinuation

Fractyl Health Inc GUTS:

• FRACTYL HEALTH ANNOUNCES GROUNDBREAKING DATA FROM REMAIN-1 MIDPOINT COHORT SHOWING REVITA® MAINTAINED WEIGHT LOSS AFTER GLP-1 DISCONTINUATION

• FRACTYL HEALTH INC - STUDY MET 3-MONTH EFFICACY ENDPOINT WITH STRONG STATISTICAL SIGNIFICANCE

• FRACTYL HEALTH INC - REVITA PROCEDURE DEMONSTRATED EXCELLENT SAFETY AND TOLERABILITY TO DATE